Market Cap 81 Billion
Bristol-Myers Squibb Co discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs.
EPS 0.88 P/E Ratio 15.35
Previous Thu, Jul 25, 2019
Latest Thu, Oct 31, 2019 (In 12 days)
Yield 3.09% / $1.64
Ex-Date Thu, Oct 3, 2019 (16 days ago)
Pay Date Fri, Nov 1, 2019
Jul 23, 2019
Oct 19, 2018
|Symbol||Price||Day Δ||YTD Δ|
How can we make Symbol Surfing better?
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.